Research
In 2021, the University of Toronto ranked first in Canada and fifth globally in the number of publications related to COVID-19. Many of these publications leveraged the Toronto High Containment Facility and the expertise of our faculty members in infectious diseases, immunology, genomics and engineering.
With a fundamental focus on trainee development and interdisciplinary research, EPIC supports continual innovation in infectious disease research through annual funding programs. In addition, our rapid research response programs mobilize the EPIC community around emerging threats such as the global mpox outbreak in 2022 and highly pathogenic avian influenza (HPAI) in 2025.
Below are some research impact key metrics from our first three years (2022-2025).
Peer-reviewed publications to which EPIC directly contributed
Total leveraged funding obtained by EPIC researchers
Academic, industry and government agency partners
Our research investment
A central part of EPIC’s mission is to advance collaborative and innovative research on infectious diseases. We offer three types of funding supports for investigator-led research projects and six different trainee awards. Please visit the Opportunities page on our website to learn more about these competitions.
Awarded in research funding programs
Trainees supported
Investigator-led projects supported
To learn more about the projects and trainees we are supporting, please visit the Funded Initiatives page on our website.
